Association of serial biochemical markers with acute ischemic stroke: The National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study

Stroke

Volumn 37, Issue 10, 2006, Pages 2508-2513

  Jauch, Edward C ^a   Lindsell, Christopher ^a   Broderick, Joseph ^a   Fagan, Susan C ^c,d   Tilley, Barbara C ^b   Levine, Steven R ^e  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrinolytics; Ischemic stroke; Myelin basic protein; Neuron specific enolase; S100 ; Thrombomodulin

Indexed keywords

FIBRINOLYTIC AGENT; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B; THROMBOMODULIN;

ADULT; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; BRAIN DAMAGE, CHRONIC; BRAIN INFARCTION; BRAIN ISCHEMIA; DOUBLE-BLIND METHOD; ENDOTHELIAL CELLS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYELIN BASIC PROTEINS; NERVE GROWTH FACTORS; NEUROGLIA; NEURONS; PHOSPHOPYRUVATE HYDRATASE; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS; S100 PROTEINS; THROMBOMODULIN; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33748988163     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000242290.01174.9e     Document Type: Article

References (30)

1. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28:1956-1960.
2. Rosen H, Sunnerhagen KS, Herlitz J, Blomstrand C, Rosengren L. Serum levels of the brain-derived proteins s-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation. 2001;49:183-191.
3. Stevens H, Jakobs C, de Jager AE, Cunningham RT, Korf J. Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest. 1999;29:6-11.
4. Tumani H, Otto M, Gefeller O, Wiltfang J, Herrendorf G, Mogge S, Steinhoff BJ. Kinetics of serum neuron-specific enolase and prolactin in patients after single epileptic seizures. Epilepsia. 1999;40:713-718.
5. Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol. 1995;43:267-270; discussion 270-271.
6. Boullerne AI, Rodriguez JJ, Touil T, Brochet B, Schmidt S, Abrous ND, Le Moal M, Pua JR, Jensen MA, Mayo W, Arnason BG, Petry KG. Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci. 2002;22:123-132.
7. Chamczuk AJ, Ursell M, O'Connor P, Jackowski G, Moscarello MA. A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. J Immunol Methods. 2002;262:21-27.
8. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke. 1999;30:1190-1195.
9. Hill MD, Jackowski G, Bayer N, Lawrence M, Jaeschke R. Biochemical markers in acute ischemic stroke. Can Med Assoc J. 2000;162:1139-1140.
10. Jauch EC, Byars C, Liu T, Kothari K, Pancioli A, Takahashi M. Preliminary evaluation of five serum markers as indicators of CNS injury in acute neurovascular events. Acad Emerg Med. 1999;6:457-458.
11. Bottiger BW, Mobes S, Glatzer R, Bauer H, Gries A, Bartsch P, Motsch J, Martin E. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation. 2001;103:2694-2698.
12. Georgiadis D, Berger A, Kowatschev E, Lautenschlager C, Borner A, Lindner A, Schulte-Mattler W, Zerkowski HR, Zierz S, Deufel T. Predictive value of S-100β and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg. 2000;119:138-147.
13. Reynolds MA, Kirchick HJ, Dahlen JR, Anderberg JM, McPherson PH, Nakamura KK, Laskowitz DT, Valkirs GE, Buechler KF. Early biomarkers of stroke. Clin Chem. 2003;49:1733-1739.
14. Steinhoff BJ, Tumani H, Otto M, Mursch K, Wiltfang J, Herrendorf G, Bittermann HJ, Felgenhauer K, Paulus W, Markakis E. Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy. Epilepsy Res. 1999;36:75-82.
15. Wiesmann M, Missler U, Hagenstrom H, Gottmann D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 1997;139:1155-1160.
16. Jansson JH, Boman K, Brannstrom M, Nilsson TK. High concentration of thrombomodulin in plasma is associated with hemorrhage: a prospective study in patients receiving long-term anticoagulant treatment. Circulation. 1997;96:2938-2943.
17. Nomura E, Kohriyama T, Kozuka K, Kajikawa H, Nakamura S, Matsumoto M. Significance of serum soluble thrombomodulin level in acute cerebral infarction. Eur J Neurol. 2004;11:329-334.
18. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
19. Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, Haley EC Jr, Brott TG, Broderick JP, Horowitz S, Lyden PD, Lewandowski CA, Marler JR, Welch KM. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA. 2001;286:2830-2838.
20. NINDS rt-PA Stroke Study Group. Effect of rt-PA on ischemic stroke lesion size by computed tomography: preliminary results from the NINDS rt-PA stroke trial. Stroke. 1998;29:287.
21. Takahashi M, Chamczuk A, Hong Y, Jackowski G. Rapid and sensitive immunoassay for the measurement of serum S100β using isoform-specific monoclonal antibody. Clin Chem. 1999;45:1307-1311.
22. Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S. Endothelial markers and adhesion molecules in acute ischemic stroke: sequential change and differences in stroke subtype. Atherosclerosis. 2002;161:161-168.
23. Ito Y, Nakachi K, Imai K, Hashimoto S, Watanabe Y, Inaba Y, Tamakoshi A, Yoshimura T. Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor β, soluble FAS, and superoxide dismutase activity for the JACC study. J Epidemiol. 2005;15(suppl 1):S67-S73.
24. Fassbender K, Schmidt R, Schreiner A, Fatar M, Muhlhauser F, Daffertshofer M, Hennerici M. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997;148:101-105.
25. Lynch JR, Laskowitz DT. Panel of serum markers for rapid diagnosis of acute stroke: response. Stroke. 2004.
26. Anand N, Stead LG. Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Dis. 2005;20:213-219.
27. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100β and glial fibrillary acidic protein. Stroke. 2000;31:2670-2677.
28. Foerch C, du Mesnil de Rochemont R, Singer O, Neumann-Haefelin T, Buchkremer M, Zanella FE, Steinmetz H, Sitzer M. S100β as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion. J Neurol Neurosurg Psychiatry. 2003;74:322-325.
29. Ikeda Y, Umemura K. Analysis of reference values of serum S100β concentrations of japanese adults. Rinsho Byori. 2005;53:395-399.
30. Cobbaert C, Hermens WT, Kint PP, Klootwijk PJ, Van de Werf F, Simoons ML. Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins. Cardiovasc Res. 1997;33:147-155.